211 related articles for article (PubMed ID: 7796348)
1. Amylin increases bone volume but cannot ameliorate diabetic osteopenia.
Romero DF; Bryer HP; Rucinski B; Isserow JA; Buchinsky FJ; Cvetkovic M; Liu CC; Epstein S
Calcif Tissue Int; 1995 Jan; 56(1):54-61. PubMed ID: 7796348
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
[TBL] [Abstract][Full Text] [Related]
3. Amylin and bone metabolism in streptozotocin-induced diabetic rats.
Horcajada-Molteni MN; Chanteranne B; Lebecque P; Davicco MJ; Coxam V; Young A; Barlet JP
J Bone Miner Res; 2001 May; 16(5):958-65. PubMed ID: 11341342
[TBL] [Abstract][Full Text] [Related]
4. Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.
Joffe I; Katz I; Sehgal S; Bex F; Kharode Y; Tamasi J; Epstein S
Calcif Tissue Int; 1993 Jul; 53(1):45-52. PubMed ID: 8348384
[TBL] [Abstract][Full Text] [Related]
5. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
Mann GN; Jacobs TW; Buchinsky FJ; Armstrong EC; Li M; Ke HZ; Ma YF; Jee WS; Epstein S
Endocrinology; 1994 Sep; 135(3):1077-83. PubMed ID: 8070349
[TBL] [Abstract][Full Text] [Related]
7. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
Sass DA; Bowman AR; Yuan Z; Ma Y; Jee WS; Epstein S
Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
[TBL] [Abstract][Full Text] [Related]
8. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status.
Gutiérrez-Rojas I; Lozano D; Nuche-Berenguer B; Moreno P; Acitores A; Ramos-Álvarez I; Rovira A; Novials A; Martín-Crespo E; Villanueva-Peñacarrillo ML; Esbrit P
Mol Cell Endocrinol; 2013 Jan; 365(2):309-15. PubMed ID: 23178165
[TBL] [Abstract][Full Text] [Related]
9. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
Katz I; Li M; Joffe I; Stein B; Jacobs T; Liang XG; Ke HZ; Jee W; Epstein S
J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
[TBL] [Abstract][Full Text] [Related]
10. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
[TBL] [Abstract][Full Text] [Related]
11. Effect of pancreas transplantation on decreased levels of circulating bone gamma-carboxyglutamic acid-containing protein and osteopenia in rats with streptozotocin-induced diabetes.
Ishida H; Seino Y; Takeshita N; Kurose T; Tsuji K; Okamoto Y; Someya Y; Hara K; Akiyama Y; Imura H
Acta Endocrinol (Copenh); 1992 Jul; 127(1):81-5. PubMed ID: 1387756
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
Bryer HP; Isserow JA; Armstrong EC; Mann GN; Rucinski B; Buchinsky FJ; Romero DF; Epstein S
J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
[TBL] [Abstract][Full Text] [Related]
13. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
Joffe I; Katz I; Jacobs T; Stein B; Takizawa M; Liu C; Berlin J; Epstein S
Endocrinology; 1992 Mar; 130(3):1578-86. PubMed ID: 1537307
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling.
Glajchen N; Epstein S; Ismail F; Thomas S; Fallon M; Chakrabarti S
Endocrinology; 1988 Jul; 123(1):290-5. PubMed ID: 3133194
[TBL] [Abstract][Full Text] [Related]
15. Calcitropic hormones and IGF-I are influenced by dietary protein.
Dubois-Ferrière V; Brennan TC; Dayer R; Rizzoli R; Ammann P
Endocrinology; 2011 May; 152(5):1839-47. PubMed ID: 21343254
[TBL] [Abstract][Full Text] [Related]
16. [Effects of vanadyl sulfate on osteopenia in streptozotocin-induced diabetic (STZD) rats. Comparison with those of insulin].
Arai M
Nihon Yakurigaku Zasshi; 1992 Nov; 100(5):401-14. PubMed ID: 1464399
[TBL] [Abstract][Full Text] [Related]
17. Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.
Mann GN; Sass DA; Chen HK; Buchinsky FJ; Bryer HP; Ma YF; Jee WS; Rucinski B; Epstein S
Calcif Tissue Int; 1996 Jul; 59(1):38-44. PubMed ID: 8661983
[TBL] [Abstract][Full Text] [Related]
18. Osteopenia: a bone disorder associated with diabetes mellitus.
Duarte VM; Ramos AM; Rezende LA; Macedo UB; Brandão-Neto J; Almeida MG; Rezende AA
J Bone Miner Metab; 2005; 23(1):58-68. PubMed ID: 15616896
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effects of l-arginine and soy enriched diet on bone homeostasis abnormalities in streptozotocin-induced diabetic rats.
El-Maraghy SA; Mehana NA
Chem Biol Interact; 2015 Mar; 229():9-16. PubMed ID: 25617479
[TBL] [Abstract][Full Text] [Related]
20. Osteopenia in genetically diabetic DB/DB mice and effects of 1alpha-hydroxyvitamin D3 on the osteopenia. Basic Research Group.
Takeshita N; Mutoh S; Yamaguchi I
Life Sci; 1995 Feb; 56(13):1095-101. PubMed ID: 9001443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
